Literature DB >> 3891061

Hemolytic-uremic syndrome associated with verotoxin-producing Escherichia coli.

S Ratnam, S March, C Ojah, D Hillman, R Ozere.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891061      PMCID: PMC1346065     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

Review 1.  Hemolytic-uremic syndrome.

Authors:  M H Goldstein; J Churg; L Strauss; D Gribetz
Journal:  Nephron       Date:  1979       Impact factor: 2.847

2.  Haemolytic uraemic syndrome and alpha-haemolytic Escherichia coli.

Authors:  L Emödy; M Kerényi; I Bátai; S Pácsa; J Székely; M Kellermayer
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

3.  Escherichia coli cytotoxin, haemolytic-uraemic syndrome, and haemorrhagic colitis.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; B T Steele
Journal:  Lancet       Date:  1983-12-03       Impact factor: 79.321

Review 4.  Hemolytic-uremic syndrome. Current concepts and management.

Authors:  J S Fong; J P de Chadarevian; B S Kaplan
Journal:  Pediatr Clin North Am       Date:  1982-08       Impact factor: 3.278

Review 5.  The haemolytic-uraemic syndrome.

Authors:  A Pauls; K Schaefer
Journal:  Contrib Nephrol       Date:  1980       Impact factor: 1.580

6.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

7.  Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin.

Authors:  A O O'Brien; T A Lively; M E Chen; S W Rothman; S B Formal
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

  7 in total
  2 in total

1.  The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.

Authors:  S W Lindgren; J E Samuel; C K Schmitt; A D O'Brien
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

2.  Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model.

Authors:  S W Lindgren; A R Melton; A D O'Brien
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.